Massimo Giachetti The U.S. FDA has granted an additional approval for Pfizer’s (NYSE:PFE) antibody-drug conjugate Adcetris (brentuximab vedotin), this time…
Maskot Biohaven (NYSE:BHVN) and Merus N.V. (NASDAQ:MRUS) Sunday reported a research collaboration and license agreement to co-develop three novel bispecific…
